Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kumar Inturi Bharath"'
Autor:
Jin Jun-O, Priyanka Bhimaneni Sai, Viola Miranda Adriana, Singh Kavita, Kumar Anoop, Matiashova Lolita, Dhar Amrit, B.R Shrinidhi, S. Chauhan Pallavi, Jain Singhai Nidhi, Papakosta Vasiliki, Yadav Smriti, Mishra Meerambika, Zacharopoulou Lefkothea, Yadav Dhananjay, Ramteke Suman, Barreca Davide, V. Pujar Gurubasavaraj, Danilchenko Valeriia, Ganesh Neenu, Tsagkaris Christos, H.J Pooja, Kumar Inturi Bharath
Publikováno v:
Anti-Infective Agents. 18:326-331
Japanese encephalitis virus (JEV) is an arthropod-borne flavivirus that belongs to the Flaviviridae family affecting millions of people worldwide. There is no specific drug approved for the treatment of this infection and also available vaccines are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::527e1569bb520a4f0a0b7b8bdbcc19a5
https://doi.org/10.2174/2211352518666200108092127
https://doi.org/10.2174/2211352518666200108092127
Autor:
H.J Pooja, Ganesh Neenu, Kumar Inturi Bharath, B.R Shrinidhi, Yadav Smriti, V. Pujar Gurubasavaraj
Publikováno v:
Anti-Infective Agents. 18:375-383
Background: To overcome one of the resistance mechanisms of Isoniazid (INH), there is a need for an antitubercular agent that can inhibit InhA enzyme by circumventing the formation of INH-NAD+ adduct. Objective: The objective of the study is the deve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e88701c550353e579abfe47e78610496
https://doi.org/10.2174/2211352518666200108091454
https://doi.org/10.2174/2211352518666200108091454
Autor:
Siraj Bushra, S. Chauhan Pallavi, Jin Jun-O, Kumar Inturi Bharath, Prakash Singh Prem, Ganesh Neenu, Kumar Dubey Sunil, Singh Kavita, Priyanka Bhimaneni Sai, Maria Faisca Phillips Ana, Wadood Abdul, Maniscalco Mauro, B.R Shrinidhi, V. Pujar Gurubasavaraj, Kumar Anoop, Sikander Azam Syed, Yadav Smriti, H. Al-Mazroea Abdulhadi, H.J Pooja, Mishra Meerambika, Gorantla Srividya, Rafi Sidra, Justin Carlus S., Singhvi Gautam, Uddin Reaz, M. Abdallah Atiyeh, M. Al-Harbi Khalid, Krishna Rapalli Vamshi, Hannah Carlus Fiona, Waghule Tejashree, Yadav Dhananjay, Khalid Al-Harbi Mazen, Narayan Saha Ranendra
Publikováno v:
Letters in Drug Design & Discovery. 17:1027-1035
Background: Aminoglycoside 6'-N-acetyltransferase type Ib (AAC(6')-Ib) from Klebsiella pneumoniae is an established drug target and has conferred insensitivity to aminoglycosides. Aminoglycosides are often inactivated by aminoglycoside modifying enzy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b2da6fdef27b8745e8cfb4d97b8f5ee
https://doi.org/10.2174/1570180817666200108095912
https://doi.org/10.2174/1570180817666200108095912